These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 33909544)

  • 21. Accurate p-values for adaptive designs with binary endpoints.
    Heritier S; Lloyd CJ; Lô SN
    Stat Med; 2017 Jul; 36(17):2643-2655. PubMed ID: 28470713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Weighted false discovery rate controlling procedures for clinical trials.
    Benjamini Y; Cohen R
    Biostatistics; 2017 Jan; 18(1):91-104. PubMed ID: 27445132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlling the familywise error rate in functional neuroimaging: a comparative review.
    Nichols T; Hayasaka S
    Stat Methods Med Res; 2003 Oct; 12(5):419-46. PubMed ID: 14599004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weighted multiple testing correction for correlated tests.
    Xie C
    Stat Med; 2012 Feb; 31(4):341-52. PubMed ID: 22114000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Dunnett-Bonferroni-based parallel gatekeeping procedure for dose-response clinical trials with multiple endpoints.
    Xu H; Nuamah I; Liu J; Lim P; Sampson A
    Pharm Stat; 2009; 8(4):301-16. PubMed ID: 19065544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Power and sample size when multiple endpoints are considered.
    Senn S; Bretz F
    Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A less conservative method to adjust for familywise error rate in neuropsychological research: the Holm's sequential Bonferroni procedure.
    Eichstaedt KE; Kovatch K; Maroof DA
    NeuroRehabilitation; 2013; 32(3):693-6. PubMed ID: 23648625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How to deal with multiple endpoints in clinical trials.
    Neuhäuser M
    Fundam Clin Pharmacol; 2006 Dec; 20(6):515-23. PubMed ID: 17109645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fallback tests for co-primary endpoints.
    Ristl R; Frommlet F; Koch A; Posch M
    Stat Med; 2016 Jul; 35(16):2669-86. PubMed ID: 26919166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved two-stage group sequential procedures for testing a secondary endpoint after the primary endpoint achieves significance.
    Li H; Wang J; Luo X; Grechko J; Jennison C
    Biom J; 2018 Sep; 60(5):893-902. PubMed ID: 29876964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An efficient and flexible multiplicity adjustment for chi-square endpoints.
    Wagler A; McCann M
    Math Biosci Eng; 2021 Jun; 18(5):4971-4986. PubMed ID: 34517473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On generalized fixed sequence procedures for controlling the FWER.
    Qiu Z; Guo W; Lynch G
    Stat Med; 2015 Dec; 34(30):3968-83. PubMed ID: 26228241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evaluation of methods for testing hypotheses relating to two endpoints in a single clinical trial.
    Su TL; Glimm E; Whitehead J; Branson M
    Pharm Stat; 2012; 11(2):107-17. PubMed ID: 22337619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familywise and per-family error rates of multiple comparison procedures.
    Lawrence J
    Stat Med; 2019 Aug; 38(19):3586-3598. PubMed ID: 31099904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overview of multiple testing methodology and recent development in clinical trials.
    Wang D; Li Y; Wang X; Liu X; Fu B; Lin Y; Larsen L; Offen W
    Contemp Clin Trials; 2015 Nov; 45(Pt A):13-20. PubMed ID: 26210511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Step-up testing procedure for multiple comparisons with a control for a latent variable model with ordered categorical responses.
    Lin Y; Kwong KS; Cheung SH; Poon WY
    Stat Med; 2014 Sep; 33(21):3629-38. PubMed ID: 24757077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mixture-based gatekeeping procedures in adaptive clinical trials.
    Kordzakhia G; Dmitrienko A; Ishida E
    J Biopharm Stat; 2018; 28(1):129-145. PubMed ID: 29283310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statistical power of multiplicity adjustment strategies for correlated binary endpoints.
    Leon AC; Heo M; Teres JJ; Morikawa T
    Stat Med; 2007 Apr; 26(8):1712-23. PubMed ID: 17252534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partition testing in dose-response studies with multiple endpoints.
    Liu Y; Hsu J; Ruberg S
    Pharm Stat; 2007; 6(3):181-92. PubMed ID: 17654696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluations of the Optimal Discovery Procedure for Multiple Testing.
    Rubin DB
    Int J Biostat; 2016 May; 12(1):21-9. PubMed ID: 27227716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.